A
Anthony Amoroso
Researcher at University of Maryland, Baltimore
Publications - 61
Citations - 1549
Anthony Amoroso is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Regimen & Population. The author has an hindex of 13, co-authored 59 publications receiving 1245 citations. Previous affiliations of Anthony Amoroso include University of Maryland, College Park & Global Virus Network.
Papers
More filters
Journal ArticleDOI
Temperature, Humidity, and Latitude Analysis to Estimate Potential Spread and Seasonality of Coronavirus Disease 2019 (COVID-19).
Mohammad M. Sajadi,Mohammad M. Sajadi,Parham Habibzadeh,Augustin Vintzileos,Shervin Shokouhi,Fernando Miralles-Wilhelm,Fernando Miralles-Wilhelm,Anthony Amoroso,Anthony Amoroso +8 more
TL;DR: In this cohort study of 50 cities with and without coronavirus disease 2019, areas with substantial community transmission of COVID-19 had distribution roughly along the 30° N to 50° N latitude corridor with consistently similar weather patterns, consisting of mean temperatures of 5 to 11 °C combined with low specific and absolute humidity.
Journal ArticleDOI
Temperature, Humidity and Latitude Analysis to Predict Potential Spread and Seasonality for COVID-19
Mohammad M. Sajadi,Parham Habibzadeh,Augustin Vintzileos,Shervin Shokouhi,Fernando Miralles-Wilhelm,Fernando Miralles-Wilhelm,Anthony Amoroso +6 more
TL;DR: Using weather modeling, it may be possible to predict the regions most likely to be at higher risk of significant community spread of COVID-19 in the upcoming weeks, allowing for concentration of public health efforts on surveillance and containment.
Journal ArticleDOI
Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV β-chemokines: An approach to suppress R5 strains of HIV-1
Alonsa Heredia,Anthony Amoroso,Charles B. Davis,Nhut Le,Elise Reardon,J. K. Dominique,E. Klingebiel,Robert C. Gallo,Robert R. Redfield +8 more
TL;DR: It is demonstrated that rapamycin (RAPA), a drug that disrupts IL-2 receptor signaling, reduces CCR5 surface expression on T cells at concentrations as low as 1 nM and that low concentrations of RAPA may have a role in both the treatment and prevention of HIV-1 infection.
Journal ArticleDOI
Dalbavancin use in vulnerable patients receiving outpatient parenteral antibiotic therapy for invasive gram-positive infections.
Jacqueline T. Bork,Emily L. Heil,Shanna Berry,Eurides Lopes,Rohini Dave,Bruce L. Gilliam,Anthony Amoroso +6 more
TL;DR: A possible role for dalbavancin in the treatment of non-ABSSSI invasive gram-positive infections in select vulnerable OPAT patients is demonstrated.